AI assistant
VivoSim Labs, INC. — Director's Dealing 2021
Mar 10, 2021
35369_dirs_2021-03-10_895e6bc5-843e-4c44-8228-ab676d8d9975.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2021-03-08
Reporting Person: Murphy Keith (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-08 | Common Stock | A | 20000 | $0.00 | Acquired | 66320 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-08 | Stock Option (Right to Buy) | $10.27 | A | 45000 | Acquired | 2031-03-08 | Common Stock (45000) | Direct |
| 2021-03-08 | Stock Option (Right to Buy) | $10.27 | A | 60000 | Acquired | 2031-03-08 | Common Stock (60000) | Direct |
| 2021-03-08 | Stock Option (Right to Buy) | $10.27 | A | 60000 | Acquired | 2031-03-08 | Common Stock (60000) | Direct |
Footnotes
F1: The reported securities are represented by restricted stock units, 25% of which shall vest on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
F2: 25% of the option shares vest and become exercisable on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
F3: The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $20.00 per share.
F4: The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $25.00 per share.